Curaleaf (CURLF) Stock Price, News & Analysis

Company Overview

Curaleaf Holdings, Inc. is a cannabis company that cultivates, processes, manufactures and sells cannabis products. Through its retail dispensaries and wholesale operations, the company offers flower, pre-rolls, vaporizers, edibles, concentrates, tinctures and other cannabis-derived products for medical and adult-use markets, where permitted by law.

Curaleaf markets products under brands that include Curaleaf, Select and Grassroots. Its business is primarily focused on the United States, where it operates a network of cultivation and processing facilities, dispensaries and distribution operations across multiple state-regulated cannabis markets. The company has also pursued international opportunities through its European cannabis operations.

Founded in 2010, Curaleaf has expanded through organic growth and acquisitions to become one of the larger cannabis operators in North America. The company is led by Executive Chairman Boris Jordan and Chief Executive Officer Matt Darin.

Key Stats

• Today's Range: $9.11 to $9.42
• 50-Day Range: $8.35 to $11.90
• 52-Week Range: $5.40 to $15.15
• Volume: 106,098 shs
• Average Volume: 253,518 shs
• Market Capitalization: $2.19 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.00
• Consensus Rating: Strong Buy

Curaleaf Stock Analysis - MarketRank™

Curaleaf scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.2 / 5
• Analyst Rating: Strong Buy

Consensus Rating

Curaleaf has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 2 strong buy ratings, 2 buy ratings, no hold ratings, and no sell ratings.

Downside Risk

Curaleaf has a consensus price target of $6.00, representing about 36.1% downside from its current price of $9.39.

Amount of Analyst Coverage

Curaleaf has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Curaleaf are expected to decrease in the coming year, from $0.01 to ($0.40) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Curaleaf is -72.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Curaleaf is -72.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Curaleaf has a P/B Ratio of 2.81. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.29% of the float of Curaleaf has been sold short.

Short Interest Ratio / Days to Cover

Curaleaf has a short interest ratio ("days to cover") of 1.35, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Curaleaf has recently increased by 20.66%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Curaleaf does not currently pay a dividend.

Dividend Growth

Curaleaf does not have a long track record of dividend growth.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 0.29

News Sentiment

Curaleaf has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for Curaleaf this week, compared to 3 articles on an average week.

Search Interest

8 people have searched for CURLF on MarketBeat in the last 30 days. This is an increase of 167% compared to the previous 30 days.

MarketBeat Follows

16 people have added Curaleaf to their MarketBeat watchlist in the last 30 days. This is an increase of 433% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Curaleaf insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.03% of the stock of Curaleaf is held by institutions.

Company Calendar

• Last Earnings: 8/05/2026
• Today: 10/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CURLF
• CIK: 1756770
• Web: www.curaleaf.com
• Phone: 781-451-0351
• Fax: N/A
• Employees: 5,554
• Year Founded: 2009

Price Target and Rating

• Average Price Target for Curaleaf: $6.00
• High Price Target: $6.00
• Low Price Target: $6.00
• Potential Upside/Downside: -36.1%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.50
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.13)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 939.00
• P/E Growth: N/A
• Net Income: -$231.07 million
• Net Margins: -2.62%
• Pretax Margin: -7.63%
• Return on Equity: -0.88%
• Return on Assets: -0.26%

Debt

• Debt-to-Equity Ratio: 1.06
• Current Ratio: 1.52
• Quick Ratio: 0.73

Sales & Book Value

• Annual Sales: $1.27 billion
• Price / Sales: 1.73
• Cash Flow: $0.16 per share
• Price / Cash Flow: 57.11
• Book Value: $3.34 per share
• Price / Book: 2.81

Miscellaneous

• Outstanding Shares: 233,560,000
• Free Float: N/A
• Market Cap: $2.19 billion
• Optionable: Not Optionable
• Beta: 1.55